Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI/ML Algorithm Training and Validation for the imPulse™ Tor System Self-Directed Systolic & Diastolic Blood Pressure Monitor.

NCT05386654 is registered in ClinicalTrials.gov with Level 42 AI, Inc. as lead sponsor.

NCT NCT05386654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05386654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI/ML Algorithm Training and Validation for the imPulse™ Tor System Self-Directed Systolic & Diastolic Blood Pressure Monitor.
Lead sponsor
Level 42 AI, Inc.
Phase
Observational
Overall status
Completed
Start date
May 16, 2022
Completion date
August 30, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ai-driven, self-directed blood pressure monitoring